Scholarlink

Objective <p>Delayed cerebral ischemia (DCI) is one of the most severe complications following aneurysmal subarachnoid hemorrhage (SAH) and can significantly worsen clinical outcomes. This study aimed to analyze the association between patients’ home medications and the risk of cerebral infarction and poor functional outcomes after SAH.</p> Methods <p>This retrospective analysis included 995 patients with aneurysmal SAH treated at our clinic between January 2003 and June 2016. Various demographic and clinical baseline characteristics were examined, with a particular focus on regular use of home medications. The study endpoints were the occurrence of early (within 72&#xa0;h post-SAH) and DCI-related infarcts (&gt; 72&#xa0;h) in follow-up computed tomography scans, as well as the functional disability at six months, defined as a modified Rankin Scale &gt; 2.</p> Results <p>There was no association between the occurrence of early infarcts and patients’ regular medications. In contrast, individuals with calcium channel blockers (CCB) use (<i>n</i> = 93) showed a higher rate of DCI (32.6% vs 19.3%, <i>p</i> = 0.005) and 6-months functional disability (57.8% vs 46.8%, <i>p</i> = 0.048). In multivariable analysis, CCB use was independently associated with the risk of DCI (adjusted odds ratio [aOR] = 4.05; <i>p</i> &lt; 0.0001) and functional disability after six months (aOR = 2.73; <i>p</i> = 0.036).</p> Conclusions <p>Regular CCB use was independently associated with an increased risk of DCI and functional disability at six months. These findings warrant cautious interpretation and further validation in prospective studies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The impact of home medications on the risk of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月26日

查看全文
  • Pikria Ketelauri,
  • Meltem Gümüs,
  • Hanah Hadice Karadachi,
  • Anna Michel,
  • Aigerim Togyzbayeva,
  • Laurèl Rauschenbach,
  • Nika Guberina,
  • Cornelius Deuschl,
  • Yan Li,
  • Marvin Darkwah Oppong,
  • Yahya Ahmadipour,
  • Philipp Dammann,
  • Ulrich Sure,
  • Ramazan Jabbarli

摘要

Objective

Delayed cerebral ischemia (DCI) is one of the most severe complications following aneurysmal subarachnoid hemorrhage (SAH) and can significantly worsen clinical outcomes. This study aimed to analyze the association between patients’ home medications and the risk of cerebral infarction and poor functional outcomes after SAH.

Methods

This retrospective analysis included 995 patients with aneurysmal SAH treated at our clinic between January 2003 and June 2016. Various demographic and clinical baseline characteristics were examined, with a particular focus on regular use of home medications. The study endpoints were the occurrence of early (within 72 h post-SAH) and DCI-related infarcts (> 72 h) in follow-up computed tomography scans, as well as the functional disability at six months, defined as a modified Rankin Scale > 2.

Results

There was no association between the occurrence of early infarcts and patients’ regular medications. In contrast, individuals with calcium channel blockers (CCB) use (n = 93) showed a higher rate of DCI (32.6% vs 19.3%, p = 0.005) and 6-months functional disability (57.8% vs 46.8%, p = 0.048). In multivariable analysis, CCB use was independently associated with the risk of DCI (adjusted odds ratio [aOR] = 4.05; p < 0.0001) and functional disability after six months (aOR = 2.73; p = 0.036).

Conclusions

Regular CCB use was independently associated with an increased risk of DCI and functional disability at six months. These findings warrant cautious interpretation and further validation in prospective studies.